Riverhead Capital Management’s Exact Sciences EXAS Stock Holding History

Riverhead Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2.5M	Sell	27,647 -7,114	-20%	-$811K	0.09%	284
2019 Q2	$4.1M	Buy	34,761 +1,007	+3%	+$101K	0.15%	181
2019 Q1	$2.92M	Sell	33,754 -5,000	-13%	-$426K	0.12%	231
2018 Q4	$2.44M	Sell	38,754 -556	-1%	-$38.2K	0.11%	245
2018 Q3	$3.1M	Buy	39,310 +465	+1%	+$30.3K	0.11%	237
2018 Q2	$2.32M	Sell	38,845 -2,155	-5%	-$116K	0.09%	281
2018 Q1	$1.65M	Buy	41,000 +5,900	+17%	+$288K	0.07%	313
2017 Q4	$1.84M	Buy	35,100 +1,300	+4%	+$69.4K	0.08%	286
2017 Q3	$1.59M	Buy	+33,800	New	+$1.36M	0.07%	308

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Riverhead Capital Management's EXAS Position: Q3 2019 in Review

Riverhead Capital Management reduced its Exact Sciences (EXAS) stake by 20% in Q3 2019, selling an estimated $811K and leaving 27,647 shares worth $2.5M. The position accounts for 0.09% of the portfolio, ranked #284.

Riverhead Capital Management first reported a position in EXAS in Q3 2017 and has held it in 9 quarters since. The position peaked at $4.1M in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

Riverhead Capital Management held 27,647 shares of Exact Sciences worth $2.5M as of Q3 2019.
Riverhead Capital Management sold 7,114 Exact Sciences shares in Q3 2019, an estimated $811K.
Exact Sciences made up 0.09% of Riverhead Capital Management's portfolio in Q3 2019, its #284 holding.
Riverhead Capital Management first reported a position in Exact Sciences in Q3 2017 and has held it in 9 quarters since.
Riverhead Capital Management's Exact Sciences position peaked at $4.1M in Q2 2019.
475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.